Therefore, investigating the mechanisms of bile acid metabolism regulation by GH signaling and its subsequent effects on gut microbiota may extend our understanding of pathophysiological roles of GH signaling and facilitate the exploration of therapeutic targets for metabolic diseases. Here, GH1 is linked to metabolic disease.